SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599298-24-000051
Filing Date
2024-04-03
Accepted
2024-04-03 16:42:10
Documents
14
Period of Report
2024-04-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20240402.htm   iXBRL 8-K 33318
  Complete submission text file 0001599298-24-000051.txt   188045

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20240402.xsd EX-101.SCH 2161
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20240402_def.xml EX-101.DEF 14787
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20240402_lab.xml EX-101.LAB 26043
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20240402_pre.xml EX-101.PRE 15429
18 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20240402_htm.xml XML 2735
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 24819545
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)